Goldshield appoints John Beighton
Published on: 15/07/10
UK generics company Goldshield has appointed John Beighton as chief executive.
Beighton was formerly UK managing director of Teva, and begun his pharma career with SmithKline Beecham as a medical rep.
He will be joined by new chairman Richard Connell, who has a 30-year background in the private equity business and most-recently headed up UK operations of Invesco.
Goldshield’s former chief executive Rakesh Patel and founder and former group executive director Kirti Patel have both stepped down from active management of the company but remain significant shareholders and advisors.
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
